Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ. 1988. Genetic basis of resistance to rimantadine
emerging during treatment of influenza virus infection. Journal of Virology 62(5):1508–1512
DOI 10.1128/jvi.62.5.1508-1512.1988.
Clements ML, Subbarao EK, Fries LF, Karron RA, London WT, Murphy BR. 1992. Use of
single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of
wild-type human influenza A virus for squirrel monkeys and adult human volunteers. Journal of
Clinical Microbiology 30(3):655–662 DOI 10.1128/jcm.30.3.655-662.1992.
Connor RJ, Kawaoka Y, Webster RG, Paulson JC. 1994. Receptor specificity in human, avian, and
equine H2 and H3 influenza virus isolates. Virology 205(1):17–23 DOI 10.1006/viro.1994.1615.
Dharmayanti NLPL, Hartawan R, Pudjiatmoko, Wibawa H, Hardiman, Balish A, Donis R,
Davis CT, Samaan G. 2014. Genetic characterization of clade 2.3.2.1 avian influenza A/(H5N1)
viruses, Indonesia, 2012. Emerging Infectious Diseases 20(4):671–674
DOI 10.3201/eid2004.130517.
Dharmayanti NLPI, Ibrahim F, Soebandrio A. 2010. Amantadine resistant of Indonesian H5N1
subtype influenza viruses during 2003–2008. Microbiology Indonesia 4(1):3
DOI 10.5454/mi.4.1.3.
Glaser L, Stevens J, Zamarin D, Wilson IA, García-Sastre A, Tumpey TM, Basler CF,
Taubenberger JK, Palese P. 2005. A single amino acid substitution in 1918 influenza virus
hemagglutinin changes receptor binding specificity. Journal of Virology 79(17):11533–11536
DOI 10.1128/JVI.79.17.11533-11536.2005.
Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH. 1985. The molecular basis of the specific
anti-influenza action of amantadine. The EMBO Journal 4(11):3021–3024
DOI 10.1002/j.1460-2075.1985.tb04038.x.
Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H,
Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G,
Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet
transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486(7403):420–428
DOI 10.1038/nature10831.
Klenk HD, Garten W. 1994. Host cell proteases controlling virus pathogenicity. Trends in
Microbiology 2(2):39–43 DOI 10.1016/0966-842X(94)90123-6.
Rehman et al. (2023), PeerJ, DOI 10.7717/peerj.14917
14/17
Lam TT, Hon CC, Pybus OG, Kosakovsky Pond SL, Wong RT, Yip CW, Zeng F, Leung FC.
2008. Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in
Indonesia. PLOS Pathogens 4(8):e1000130 DOI 10.1371/journal.ppat.1000130.
Lan Y, Zhang Y, Dong L, Wang D, Huang W, Xin L, Yang L, Zhao X, Li Z, Wang W, Li X, Xu C,
Yang L, Guo J, Wang M, Peng Y, Gao Y, Guo Y, Wen L, Jiang T, Shu Y. 2010. A
comprehensive surveillance of adamantane resistance among human influenza A virus isolated
from mainland China between 1956 and 2009. Antiviral Therapy 15(6):853–859
DOI 10.3851/IMP1656.
Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P,
Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT,
Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Peiris JS. 2004. Genesis of
a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature
430(6996):209–213 DOI 10.1038/nature02746.
Long JX, Peng DX, Liu YL, Wu YT, Liu XF. 2008. Virulence of H5N1 avian influenza virus
enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes 36(3):471–478
DOI 10.1007/s11262-007-0187-8.
Maines TR, Chen LM, Van Hoeven N, Tumpey TM, Blixt O, Belser JA, Gustin KM, Pearce MB,
Pappas C, Stevens J, Cox NJ, Paulson JC, Raman R, Sasisekharan R, Katz JM, Donis RO.
2011. Effect of receptor binding domain mutations on receptor binding and transmissibility of
avian influenza H5N1 viruses. Virology 413(1):139–147 DOI 10.1016/j.virol.2011.02.015.
Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA, Naffakh N, Warnes C, Altholtz M,
Donis R, Subbarao K. 2009. Neuraminidase stalk length and additional glycosylation of the
hemagglutinin influence the virulence of influenza H5N1 viruses for mice. Journal of Virology
83(9):4704–4708 DOI 10.1128/JVI.01987-08.
Mertens E, Dugan VG, Stockwell TB, Lindsay LL, Plancarte M, Boyce WM. 2013. Evaluation of
phenotypic markers in full genome sequences of avian influenza isolates from California.
Comparative Immunology, Microbiology and Infectious Diseases 36(5):521–536
DOI 10.1016/j.cimid.2013.06.003.
Mettier J, Marc D, Sedano L, Da Costa B, Chevalier C, Le Goffic R. 2021. Study of the host
specificity of PB1-F2-associated virulence. Virulence 12(1):1647–1660
DOI 10.1080/21505594.2021.1933848.
Novianti AN, Rahardjo K, Prasetya RR, Nastri AM, Dewantari JR, Rahardjo AP,
Estoepangestie ATS, Shimizu YK, Poetranto ED, Soegiarto G, Mori Y, Shimizu K,
Hotopp JCD. 2019. Whole-genome sequence of an avian influenza A/H9N2 virus isolated from
an apparently healthy chicken at a live-poultry market in Indonesia. Microbiology Resource
Announcements 8(17):e01671-18 DOI 10.1128/MRA.01671-18.
Peiris JS, de Jong MD, Guan Y. 2007. Avian influenza virus (H5N1): a threat to human health.
Clinical Microbiology Reviews 20(2):243–267 DOI 10.1128/CMR.00037-06.
Pinto LH, Holsinger LJ, Lamb RA. 1992. Influenza virus M2 protein has ion channel activity. Cell
69(3):517–528 DOI 10.1016/0092-8674(92)90452-I.
Putri K, Widyarini S, Asmara W. 2019. The thrift of avian influenza in Indonesia. In: Viruses and
Viral Infections in Developing Countries. London: IntechOpen.
Rehman S, Effendi MH, Shehzad A, Rahman A, Rahmahani J, Witaningrum AM, Bilal M. 2022.
Prevalence and associated risk factors of avian influenza A virus subtypes H5N1 and H9N2 in
LBMs of East Java province, Indonesia: a cross-sectional study. PeerJ 10(1):e14095
DOI 10.7717/peerj.14095.
Rehman et al. (2023), PeerJ, DOI 10.7717/peerj.14917
15/17
Rogers GN, Paulson JC, Daniels RS, Skehel JJ, Wilson IA, Wiley DC. 1983. Single amino acid
substitutions in influenza haemagglutinin change receptor binding specificity. Nature
304(5921):76–78 DOI 10.1038/304076a0.
Shimizu K, Wulandari L, Poetranto ED, Setyoningrum RA, Yudhawati R, Sholikhah A,
Nastri AM, Poetranto AL, Candra AYR, Puruhito EF, Takahara Y, Yamagishi Y,
Yamaoka M, Hotta H, Ustumi T, Lusida MI, Soetjipto, Shimizu YK, Soegiarto G, Mori Y.
2016. Seroevidence for a high prevalence of subclinical infection with avian influenza A/(H5N1)
virus among workers in a live-poultry market in Indonesia. Journal of Infectious Diseases
214(12):1929–1936 DOI 10.1093/infdis/jiw478.
Subbarao EK, London W, Murphy BR. 1993. A single amino acid in the PB2 gene of influenza A
virus is a determinant of host range. Journal of Virology 67(4):1761–1764
DOI 10.1128/jvi.67.4.1761-1764.1993.
Suguitan AL Jr, Matsuoka Y, Lau YF, Santos CP, Vogel L, Cheng LI, Orandle M, Subbarao K.
2012. The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/
2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in
mammals. Journal of Virology 86(5):2706–2714 DOI 10.1128/JVI.05546-11.
Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J,
Chen LM, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney PJ, Gilbert AT, Chang J,
Guo Z, Donis RO. 2013. New world bats harbor diverse influenza A viruses. PLOS Pathogens
9(10):e1003657 DOI 10.1371/journal.ppat.1003657.
Wang W, Lu B, Zhou H, Suguitan AL Jr, Cheng X, Subbarao K, Kemble G, Jin H. 2010.
Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity
synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1
A/Vietnam/1203/2004 vaccine virus in ferrets. Journal of Virology 84(13):6570–6577
DOI 10.1128/JVI.00221-10.
Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of
influenza A viruses. Microbiological Reviews 56(1):152–179 DOI 10.1128/mr.56.1.152-179.1992.
WHO H5N1. 2021. Cumulative number of confirmed human cases of avian influenza A/(H5N1)
reported to WHO. Available at https://www.who.int/publications/m/item/cumulative-numberof-confirmed-human-cases-for-avian-influenza-a(h5n1)-reported-to-who-2003-2021-15-april2021 (accessed 11 March 2021).
WHO/OIE/FAO H5N1 Evolution Working Group. 2008. Toward a unified nomenclature system
for highly pathogenic avian influenza virus (H5N1). Emerging Infectious Diseases 14(7):e1
DOI 10.3201/eid1407.071681.
WHO/OIE/FAO H5N1 Evolution Working Group. 2014. Revised and updated nomenclature for
highly pathogenic avian influenza A/(H5N1) viruses. Influenza and Other Respiratory Viruses
8(3):384–388 DOI 10.1111/irv.12230.
World Health Organization. 2015. Cumulative number of confirmed human cases for avian
influenza A/(H5N1) reported to WHO, 2003–2015. World Health Organization, Geneva,
Switzerland.
World Health Organization. 2019. Cumulative number of confirmed human cases of Avian
Influenza A/(H5N1) reported to WHO, Geneva, 3.
Yudhawati R, Prasetya RR, Dewantari JR, Nastri AM, Rahardjo K, Novianti AN, Amin M,
Rantam FA, Poetranto ED, Wulandari L, Lusida MI, Soetjipto, Soegiarto G, Shimizu YK,
Mori Y, Shimizu K. 2020. Comparison of virulence and lethality in mice for avian influenza
viruses of two A/H5N1 and one A/H3N6 isolated from poultry during year 2013–2014 in
Rehman et al. (2023), PeerJ, DOI 10.7717/peerj.14917
16/17
Indonesia. Japanese Journal of Infectious Diseases 73(5):336–342
DOI 10.7883/yoken.JJID.2020.052.
Zhang X, Chen S, Jiang Y, Huang K, Huang J, Yang D, Zhu J, Zhu Y, Shi S, Peng D, Liu X. 2015.
Hemagglutinin glycosylation modulates the pathogenicity and antigenicity of the H5N1 avian
influenza virus. Veterinary Microbiology 175(2–4):244–256 DOI 10.1016/j.vetmic.2014.12.011.
Zhou H, Yu Z, Hu Y, Tu J, Zou W, Peng Y, Zhu J, Li Y, Zhang A, Yu Z, Ye Z, Chen H, Jin M.
2009. The special neuraminidase stalk-motif responsible for increased virulence and
pathogenesis of H5N1 influenza A virus. PLOS ONE 4(7):e6277
DOI 10.1371/journal.pone.0006277.
Rehman et al. (2023), PeerJ, DOI 10.7717/peerj.14917
17/17
...